Jack A. Khattar - 06 Mar 2026 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
President, CEO, Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 16:13:50 UTC
Previous filing
03 Mar 2026
Next filing
16 Mar 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Jack A. Khattar filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 10 Mar 2026."

Quick Takeaways

  • This page summarizes Jack A. Khattar's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 10 Mar 2026, 16:13.

What Changed

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Khattar Jack A. President, CEO, Director C/O SUPERNUS PHARMACEUTICALS INC., 9715 KEY WEST AVENUE, ROCKVILLE /s/ Timothy C. Dec, as attorney-in-fact 10 Mar 2026 0001539937

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise +38,640 +3.2% $0.000000* 1,245,218 06 Mar 2026 Direct
transaction SUPN Common Stock Tax liability -16,574 -1.3% $54.73* 1,228,644 06 Mar 2026 Direct F1
holding SUPN Common Stock 1,005,600 06 Mar 2026 By the KBT Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Options Exercise -38,640 -100% $0.000000* 0 06 Mar 2026 Common Stock 38,640 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
F2 On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.

Sponsored